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Abstract
Aim of the study To report a matched-pair comparative
analysis between open (OPN) and laparoscopic partial
nephrectomy (LPN) for clinical (c) T1a renal masses from
a large prospective multicenter dataset.
Materials and methods The RECORd Project includes all
patients who underwent OPN and LPN for kidney cancer
between January 2009 and January 2011 at 19 Italian
centers. Open and laparoscopic groups were compared
regarding clinical, surgical, pathologic, functional results
and TRIFECTA outcome. Multivariable logistic regression
models were used to analyze predictors of WIT [25 min,
surgical complications (SC) and the achievement of the
TRIFECTA outcome.
Results Overall, 301 patients had OPN and 149 LPN.
Groups were matched 1:1 (140 matched pairs) for clinical
diameter, tumor location and type of indication. Laparo-
scopic partial nephrectomy was associated with a signifi-
cantly mean longer WIT (19.9 vs. 15.1 min; p \ 0.001),
and it was an independent predictor of a WIT [25 min
(RR 6.29, p \ 0.0001). The TRIFECTA was achieved in
A. Minervini  G. Siena (&)  A. Mari  M. Carini  S. Serni
Clinica Urologica I, AOUC, Universita` di Firenze, Florence,
Italy
e-mail: giampaolo.siena@gmail.com
A. Antonelli  S. Cosciani Cunico  C. Simeone
Unita` Operativa di Urologia Dipartimento di NefroUrologia,
Azienda AO Spedali Civili di Brescia, Brescia, Italy
G. Bianchi
Policlinico di Modena, Clinica Urologica,
Universita` di Modena, Modena, Italy
A. M. Bocciardi
Dipartimento Chirurgico Polispecialistico, Urologia, Azienda
Ospedaliera Ospedale Niguarda Ca’ Granda, Milan, Italy
V. Ficarra
Clinica Urologica, Universita` di Padova, Padua, Italy
C. Fiori  F. Porpiglia
Divisione di Urologia, Universita` di Torino, Ospedale San Luigi
Gonzaga, Orbassano, Torino, Italy
F. Fusco  V. Mirone
Policlinico Federico II, Universita` di Napoli, Naples, Italy
G. Martorana  R. Schiavina
Dipartimento di Urologia, Universita` di Bologna, Ospedale S.
Orsola-Malpighi, Bologna, Italy
M. Medica
Ospedale Sestri Levante, Sestri Levante, Italy
G. Morgia
Luna Foundation, Rome, Italy
F. Rocco
UOC Urologia Ospedale Maggiore Ca’ Granda Policlinico
Mangiagalli Regina Elena Universita` degli Studi di Milano,
Milan, Italy
B. Rovereto
I.R.C.C.S. Policlinico San Matteo, Struttura Di Urologia,
Pavia, Italy
C. Terrone  A. Volpe
Dipartimento di Urologia, Azienda Ospedaliera Maggiore
Della Carita`, Universita` del Piemonte Orientale,
Novara, Italy
123
World J Urol
DOI 10.1007/s00345-013-1155-7
78.6 and 74.3 % after OPN and LPN (p = ns), respec-
tively, and the surgical approach was not a predictor of a
negative TRIFECTA and SC at multivariable analysis. At
6-month follow-up, no significant differences were
observed between the OPN and LPN group both in esti-
mated glomerular filtration rate (eGFR) (DGFR 1.1 vs.
4.1 mL/min) and in new-onset stage III–V chronic kidney
disease (CKD) rate (0 vs. 0.7 %).
Conclusion No significant difference in achieving the
TRIFECTA outcome was reported after OPN and LPN.
LPN was associated with a significantly longer WIT.
However, eGFR at 6-month follow-up did not differ sig-
nificantly between the two surgical approaches.
Keywords Laparoscopic partial nephrectomy 
Open partial nephrectomy  Kidney cancer 
Laparoscopic versus open matched-pair comparison 
TRIFECTA
Introduction
Incidental diagnosis of small renal masses (SRMs) is
increased because of improvement and widespread use of
imaging techniques [1]. Despite recent developments in
probe-ablative therapies, surgical excision remains the
cornerstone of treatment [2]. Open partial nephrectomy
(OPN) performed with the excision of a minimal tumor-
free surgical margin or as simple enucleation (SE) is con-
sidered the gold standard for the treatment of SRMs [3, 4].
Laparoscopic PN (LPN) is a viable treatment option;
nevertheless, it continues to be performed in a minority of
centers [5–7]. Indeed, LPN has been associated in some
retrospective observational studies with a steep learning
curve, more postoperative complications, particularly uro-
logical, and an increased number of subsequent procedures
[7]. To compare the two approaches, we report a matched-
pair analysis between OPN and LPN for cT1a SRMs from a
large prospective multicenter dataset, evaluating clinical,
surgical, pathologic, functional results and the simulta-
neous achievement of the TRIFECTA outcomes (defined as
warm ischemia time \25 min, negative surgical margins
and no perioperative complications) [8, 9].
Patients and methods
The Italian Registry of Conservative Renal Surgery
(RECORd Project) is a 4-year prospective observational
multicenter study promoted by the Leading Urological No
profit foundation Advanced (LUNA) research of the So-
cieta` Italiana di Urologia (SIU). The study includes all
patients who underwent OPN and LPN for radiologically
diagnosed SRMs between January 2009 and January 2011
at 19 urological Italian centers. An online database was
generated, and it comprises five main folders: (1) Anthro-
pometric and Preoperative data; (2) Imaging, Indications
and Comorbidities; (3) Intraoperative Data; (4) Postoper-
ative Data; and (5) Histopathological Analysis. All data
were centrally recorded on a data server.
Overall, information about 554 patients was collected.
Surgical indications were defined as elective (localized
unilateral RCC with healthy contralateral kidney), relative
(localized unilateral RCC with the coexistence of comor-
bidities such as diabetes, hypertension and lithiasis that
could potentially affect kidney function in the future) and
absolute (bilateral tumors, multiple tumors, moderate to
severe chronic kidney disease or in case of neoplasia
involving an anatomically or functionally solitary kidney).
The laparoscopic and open approaches as well as the
surgical technique, performed in the form of PN and SE,
were adopted according to the center’s and surgeon’s
preference. Standard PN has been defined as the excision of
the tumor and of a minimal margin of healthy peritumoral
renal parenchyma [3]. SE has been defined as the blunt
tumor excision without removing a visible rim of paren-
chymal tissue around the pseudocapsule [3].
All significant patients’ and tumors’ characteristics were
collected. Performance status was assigned according to
the ECOG criteria [10]. Mode of presentation was distin-
guished according to the Patard classification [11].
Tumors were classified according to their location on the
longitudinal plane (upper pole, middle part and lower pole)
and on the transverse plane (anterior surface, posterior
surface, lateral margin, medial margin, perihilar) of the
kidney. Perihilar position was defined as tumor in conti-
guity with main artery or vein and/or first-order branches at
the preoperative imaging. According to the degree of depth
into the kidney, each tumor was also classified into three
growth pattern categories: (1) prevalently (C50 %) exo-
phytic, (2) prevalently endophytic (\50 % exophytic) and
(3) completely endophytic.
All surgical specimens were processed according to the
standard pathologic procedures at each institution by
experienced uropathologists. Tumors were pathologically
staged according to the American Joint Committee on
Cancer–Union Internationale Contre le Cancer TNM clas-
sification, and surgical margin status was reported [12].
The Heidelberg and Fuhrman classifications were used to
assign the histologic type and nuclear grade, respectively
[13, 14].
The severity of surgical complications was graded
according to the modified Clavien system [15].
TRIFECTA outcome was defined as a combination of
warm ischemia time (WIT) \25 min, negative surgical
margins and no perioperative complications [8, 9].
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Renal function was measured as creatinine level and
estimated glomerular filtration rate (eGFR) using the
Modification of Diet in Renal Disease (MDRD) formula, at
baseline, third postoperative day and at 6-month follow-up.
Chronic kidney disease (CKD) stage III–V rate was
recorded at baseline and at 6-month follow-up.
Statistical analysis
A propensity score matching was performed to adjust for
preoperative variables using R Project using multivariable
logistic regression based upon the covariates: clinical
tumor size (continue variable), type of indication and
tumor location [16, 17]. The matching was carried out with
a 1:1 ratio with respect to the surgical approach (LPN vs.
OPN) with a C statistic of 0.65.
Continuous variables were reported as mean (SD) or as
median and IQR, as appropriate. The Student’s t test and
the Mann–Whitney U test were used to compare continu-
ous variables, and the Pearson chi-square test was used to
compare categorical variables. Multivariable logistic
regression models were applied to analyze the predictors of
WIT [25 min, surgical complications and TRIFECTA
outcome. Statistical significance was set as p B 0.05. All
reported p values are two-sided. Analyses were performed
with SPSS version 17.0 (SPSS Inc, Chicago, IL, USA) by
two of the authors (AM, AM).
Results
A total of 554 patients were included in the dataset.
Overall, 104 patients were excluded for the following
reasons: T1b tumor stage (91 patients), metastatic disease
(2 patients) and incomplete data (11 patients). Overall, 450
patients were the subject of the final analysis. Three hun-
dred one had OPN and 149 LPN. Groups were matched 1:1
(140 matched pairs) for clinical diameter, tumor side and
type of indication. Patients’ and tumors’ characteristics and
intraoperative data for both treatment groups are reported
in Table 1. No statistically significant differences between
the two groups were present for age, performance status,
symptoms at diagnosis, tumor growth pattern, preoperative
hemoglobin, creatinine, eGFR as well as for the operative
times (131 vs. 143 min), the surgical technique (SE vs.
standard PN) and hilar control.
Mean intraoperative blood loss (IBL) was slightly
higher for the OPN group, but it did not reach the statistical
significance (221 vs. 164 cc; p = ns). LPN was associated
with significantly mean longer WIT compared to OPN
(19.9 vs. 15.1 min; p \ 0.001).
Factors predicting WIT [25 min at the univariable
analysis were the laparoscopic approach, tumor growth
pattern C50 % endophytic and mesorenal tumor location. At
multivariable analysis, only the laparoscopic approach was
confirmed as an independent predictors of a WIT [25 min.
The risk of WIT [25 min in patients undergoing LPN was
6.3 times greater than in patients undergoing OPN (RR 6.29;
95 % CI 2.47–16.07; p \ 0.0001).
At the pathological analysis, the incidence of PSM was
not significantly different between both groups (3.5 vs.
3 %, OPN vs. LPN), and at univariable analysis, the only
factor that correlated with the risk of PSM was the type of
indication (relative/absolute). Mean length of stay (SD)
was 5 (3) and 6 (3) days in the LPN and OPN groups,
respectively (p: 0.005).
Overall, 46 complications occurred, and no statistical
difference was observed between the OPN and LPN groups
(17.9 vs. 15 %). Intraoperative SC rate was higher after OPN
versus LPN (5 vs. 0.7 %, p = 0.03). No statistically signif-
icant differences in Clavien grade II and III SC were seen
between the two groups. No grade IV and V SC occurred in
our series (Table 2). At the multivariable analysis, the fac-
tors independently associated with the risk of SC were
clinical tumor size (RR 1.83; 95 % CI 1.21–2.78; p: 0.004)
and the type of indication, with a threefold increased risk of
SC in case of relative/absolute indication of PN.
No difference was observed in achieving the TRI-
FECTA outcome simultaneously after OPN versus LPN
(78.6 vs. 74.3 %; p = ns). At multivariable analysis, tumor
size and type of indication almost doubled the risk of not
achieving the TRIFECTA (Table 3).
At 6-month follow-up, no difference in eGFR from
baseline was observed between the OPN and LPN groups
(1.1 vs. 4.1 mL/min; p = ns), and no significative difference
in new-onset stage III–V CKD rate at 6-month follow-up
with baseline was recorded (0 vs. 0.7 %; p = ns) (Table 2).
Discussion
In our study we report a high rate of simultaneous achieve-
ment of the TRIFECTA outcomes after OPN (78.6 %) and
LPN (74.3 %), with no statistical difference between the two
approaches. In a recent publication, Kalifeh et al. reported a
31.6 % simultaneous achievement of the TRIFECTA out-
come in a large single-surgeon LPN series; this lower rate
can be explained by the preliminary worldwide experience
with LPN at the time of their earlier cases and the different
inclusion criteria used [8]. Indeed, data reported by Hung
et al. in the ‘‘recent surgical era’’ where all T1 stages were
included showed that the TRIFECTA outcomes were
simultaneously achieved in 68 % of the cases. The lower rate
compared to the present paper can be explained by the
slightly different definition of TRIFECTA made by the
authors, defined as negative cancer margin, minimal renal
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functional decrease and no urological complications [9]. In
our report at multivariable analysis, the surgical approach
was not a predictor of a negative TRIFECTA achievement.
The only factors independently associated with a risk of a
Table 1 Preoperative patients’ and tumor’s characteristics
Open NSS VLP NSS p
Age
Mean, SD 63.0 (11.2) 62.2 (12.0) 0.57
B65 n, (%) 68 (48.6 %) 69 (49.3 %) 0.95
[65 n, (%) 72 (51.4 %) 71 (50.7 %)
BMI, Mean (SD) 26.6 (4.2) 26.1 (3.6) 0.29
Gender 0.53
Male n, (%) 87 (62.1 %) 92 (65.7 %)
Female n, (%) 53 (37.9 %) 48 (44.3 %)
Tumor side 0.83
Right n, (%) 72 (51.4 %) 71 (50.7 %)
Left n, (%) 68 (48.6 %) 69 (49.3 %)
ECOG 0.32
0 87 (62.1 %) 95 (67.9 %)
C1 53 (47.9 %) 45 (32.1 %)
Symptoms at diagnosis 0.21
Asymptomatic 119 (85 %) 111 (79.3 %)
Symptomatic 21 (15 %) 29 (20.7 %)
Clinical size, mean
(SD)
2.48 (0.8) 2.46 (0.8) 0.85
Tumor location 0.88
Polar 81 (57.9 %) 82 (58.6 %)
Mesorenal 59 (42.1 %) 58 (41.4 %)
Type of indication 0.99
Elective 117 (83.6 %) 117 (83.6 %)
Absolute/Relative 23 (16.4 %) 23 (16.4 %)
Tumor growth pattern 0.10
Mainly exophytic
(C50%)
105 (75 %) 113 (80.7 %)
Mainly endophytic
([50%)
31 (22.1%) 27 (19.3 %)
Completely
endophytic
4 (2.9 %) 0
Tumor site 0.40
Perihilar 5 (3.6 %) 3 (2.1 %)
Medial margin 40 (28.6 %) 33 (23.6 %)
Lateral margin 33 (23.6 %) 47 (33.5 %)
Anterior aspect 10 (7.1 %) 11 (7.9 %)
Posterior aspect 52 (37.1 %) 46 (32.9 %)
Preoperative HB level,
mean (SD)
14.2 (1.4) 14.4 (1.4) 0.21
Preoperative HTC
level, mean (SD)
42.1 (4.4) 42.4 (4.0) 0.48
Preoperative creatinine
level, mean (SD)
0.96 (0.45) 0.92 (0.29) 0.33
Preoperative GFR
using MDRD, mean
(SD)
83.3 (22.5) 87.3 (23.1) 0.15
Surgical technique 0.26
SE n, (%) 66 (47.1%) 75 (53.6 %)
Standard PN n, (%) 74 (52.9 %) 65 (46.4 %)
Table 2 Incidence of complications, TRIFECTA, chronic kidney
disease (CKD) and eGFR and creatinine level variation, according to
the surgical approach adopted
Open
NSS
VLP NSS p
Total 25
(17.9%)
21 (15%) 0.34
Medical 7 (5%) 5 (3.5%) 0.51
Surgical intraoperative 7 (5%) 1 (0.7%) 0.03
Surgical postoperative 18
(12.9%)
16 (11.4%) 0.63
Surgical Clavien II 9 (6.4%) 8 (5.7%) 0.80
Surgical Clavien III 4 (2.9%) 7 (5%) 0.36
TRIFECTA* 110
(78.6%)
104 (74.3%) 0.40
Preoperative CKD stage III–V
(%)
21 (15) 17 (12.1) 0.49
Delta creatinine level pre-op—
3rd day post-op, mean (SD)
0.05
(0.53)
0.21 (0.20) 0.02
Delta creatinine level pre-op—6-
month follow-up, mean (SD)
0.07
(0.20)
0.10 (0.18) 0.40
Delta GFR using MDRD pre-
op—3rd day post-op, mean
(SD)
13.1
(14.5)
24.4 (24.1) 0.008
Delta GFR using MDRD pre-
op—6-month follow-up, mean
(SD)
1.1 (17) 4.1 (22.7) 0.19
New-onset CKD stage III–V at
6-month follow-up (%)
0 1 (0.7) 0.87
Table 1 continued
Open NSS VLP NSS p
Hilar clamping 0.37
Yes n, (%) 90 (64.3 %) 97 (69.3 %)
No n, (%) 50 (35.7 %) 43 (30.7 %)
Type of ischemia 0.06
Warm n, (%) 135 (96.4 %) 140 (100 %)
Cold n, (%) 5 (3.6 %) 0 (0 %)
Ischemic time (min)
mean (SD)
15.7 (5.9) 19.9 (6.8) \0.0001
Operative time (min)
mean (SD)
131.2 (58.1) 143.0 (56.9) 0.09
Intraoperative blood
loss (cc), mean (SD)
221 (399.1) 164 (147.8) 0.11
Delta HB level, mean
(SD)
2.7 (3.18) 2.2 (1.9) 0.08
HTC Hematocrit
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negative TRIFECTA achievement were the relative/absolute
indication and the clinical tumor size: Each 1-cm increase in
tumor size doubled the risk of not achieving TRIFECTA
(Table 3). Moreover, no significant difference in operative
time, hilar clamping and intraoperative blood loss was
observed between the two approaches. While the laparo-
scopic approach was associated with a significantly mean
longer WIT, at multivariable analysis LPN was an inde-
pendent predictors of a WIT [25 min. This is in line with
most of the recent comparative studies between LPN and
OPN, where LPN results constantly associated with a longer
WIT, although some authors reported shorter WIT in their
LPN series [6, 7, 18, 19]. Consequently, in our LPN cohort a
significantly higher eGFR variation on third postoperative
day compared to the OPN cohort was observed. However,
this significance in eGFR variation was not held after
6-month follow-up, and no significant difference in new-
onset stage III–V CKD rate at 6-months with baseline fol-
low-up was recorded (Table 2). The similar global renal
function results after OPN and LPN are supported by the data
from a recent paper by Lane et al. where the authors report
after a median follow-up of 6.6 years a median GFR
decrease of 16.9 % after LPN and 14.1 % after OPN
(p = 0.5) [18]. WIT and the quantity of remnant healthy
parenchyma are the only modifiable variables able to reduce
renal function deterioration after PN [20, 21]. However,
although WIT has been strongly associated with acute renal
failure, its correlation with chronic renal damage is contro-
versial as other factors such as the width of healthy tissue
removed with the tumor and the method of renorrhaphy or
the hemostatic energy applied on the surgical bed may play a
role in its development [22–27]. In this direction, more
detailed biomolecular and imaging tools are needed to assess
the real renal damage after this type of surgery [28].
As shown in Table 2, in the present series, no signifi-
cative differences in total complications were observed
after OPN versus LPN, whereas intraoperative SC was
significantly higher after the open versus the laparoscopic
approach. This is in contrast to a multicenter US experi-
ence, where postoperative complication rate was lower in
the OPN group (19.2 vs. 24.9 %), most certainly due to the
early worldwide experience with LPN at the time of their
study and the inclusion of cT1b RCC, accounting for 8.8 %
of all the LPN performed [7].
Furthermore, in our paper, no significative differences
between the OPN and LPN groups were observed for
surgical Clavien grade II and III complication rates.
At the multivariable analysis, the factors independently
associated with SC were clinical tumor size and indication
for surgery (relative/absolute vs. elective).
In the present series, the incidence of PSM was not
significantly different between patients treated with open
and laparoscopic PN. At univariable analysis, the only
factor that significantly correlated with the risk of PSM was
the type of indication (elective vs. relative/imperative).
To the best of our knowledge, this study is the first
matched-pair comparative analysis between OPN and LPN
that includes also the simultaneous achievement of the
Table 3 Univariable and
multivariable analysis for
TRIFECTA outcome
Univariable analysis for TRIFECTA Multivariable analysis for
TRIFECTA not reached
Reached Not Reached p RR 95% CI p
Age, mean (SD) 62.1 (11.7) 64.1 (11.3) 0.24 1.01 0.98–1.04 0.46
Tumor size, mean (SD) 2.8 (0.8) 2.4 (0.77) \0.0001 2.15 1.49–3.11 \0.0001
Surgical approach, n (%) 0.40
VLP 104 (74.3 %) 36 (25.7 %)
Open 110 (78.6 %) 30 (21.4 %)
Tumor growth pattern, n (%)
[50% exophytic 171 (78.4 %) 47 (21.6 %) 0.14
C50% endophytic 43 (69.4 %) 19 (30.6 %)
Tumor location, n (%)
Polar 128 (78.5 %) 35 (21.5 %) 0.33
Mesorenal 86 (73.5 %) 31 (26.5 %)
Symptoms at diagnosis
Asymptomatic 178 (77.4%) 52 (22.6 %) 0.41
Symptomatic 36 (72 %) 14 (28 %)
Indication
Elective 184 (78.6 %) 50 (21.4 %) 0.04 2.14 1.03–4.45 0.04
Relative/absolute 30 (65.2 %) 16 (34.8 %)
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TRIFECTA outcomes. Further strengths of our work are
the use of clinical dimensions and the stratification of the
complications according to the validated Clavien system.
Moreover, its multicenter nature might increase the exter-
nal validity of the data compared with the single-center,
single-surgeon setting and provide a valid snapshot of the
distribution and outcomes of the open and laparoscopic PN
in a European country in the last 4 years.
The main limitation of our report resides in the lack of
randomization that might confirm the superiority of one
approach over the other, but at present, it seems extremely
difficult to perform such a study owing to the difficulties of
most skilled laparoscopic surgeons in randomizing patients
with clinically T1a renal tumors in the open PN arm, as
well as the reluctance of most patients that decided to go
for a minimally invasive procedure to be operated by OPN.
Moreover, due to the short-term follow-up available,
postoperative renal function was evaluated only at
6 months, using the MDRD formula and not the sequential
scintigraphy, that could have allowed a more precise def-
inition of the function of each renal unit.
Another limitation of this study relies on the lack of a
validated nephrometric score, since the project began
before the Padua and R. E. N. A. L. score systems were
developed, although the surgical complexity was evaluated
according to multiple variables [29, 30].
Conclusions
No significant differences in achieving the TRIFECTA out-
come were reported after OPN and LPN. LPN was associated
with a significantly longer WIT compared to OPN. However,
the global renal function at 6-month follow-up did not differ
significantly between the two surgical approaches.
Conflict of interest None.
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